OM compared with TIL: revenue, margins and what each company keeps, and the suppliers and customers both name

OMOutset Medical, Inc.

Mkt capRevenueRevenue

TILInstil Bio, Inc.

Mkt capRevenueRevenue

Compare

OMOutset Medical, Inc.

TILInstil Bio, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

Supply-chain overlap

Revenue flow

OM: latest quarter is a loss; flow not drawable. TIL: latest quarter not drawable.Method ›

OMOutset Medical, Inc.

4.01▼−0.25%· post 4.15

Mkt cap$78.0MRevenue$32MQ2 FY26Revenue$119MFY25

TILInstil Bio, Inc.

6.58▲+0.46%· post 6.68

ClosedNov 3 '26

Mkt cap$46.1MRevenue—Revenue—

Compare

ClosedNov 3 '26

OMOutset Medical, Inc.

TILInstil Bio, Inc.

4.01▼−0.25%post 4.15

Price

6.58▲+0.46%post 6.68

$78.0M

Mkt cap

$46.1M

Q2 FY26$32M

Revenue

—

FY25$119M

Revenue

—

OM4.01▼−0.25%vsTIL6.58▲+0.46%ClosedNov 3 '26

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only OM 1

—Tacnaunlistedsupplier

Shared 0

No shared counterparties.

Only TIL 2

AZNAstraZeneca Pharmaceuticalscustomer

—ImmuneOnco Biopharmaceuticals (Shanghai)unlistedsupplier

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

Price

rebased to 0%

OM, solidTIL, dashed